Marietta Wealth Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Marietta Wealth Management’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-120,000	Closed	-$67.2K	–	109
2023 Q2	$67.2K	Hold	120,000	–	–	0.01%	105
2023 Q1	$137K	Hold	120,000	–	–	0.03%	107
2022 Q4	$134K	Hold	120,000	–	–	0.03%	108
2022 Q3	$252K	Hold	120,000	–	–	0.06%	99
2022 Q2	$163K	Hold	120,000	–	–	0.04%	110
2022 Q1	$203K	Buy	+120,000	New	+$172K	0.04%	109

Other funds holding RVLP

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TAM

Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Marietta Wealth Management's RVLP Position: Q3 2023 in Review

Marietta Wealth Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 120,000 shares — an estimated $67.2K sold.

Marietta Wealth Management first reported a position in RVLP in Q1 2022 and held it in 6 quarters. The position peaked at $252K in Q3 2022. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

Marietta Wealth Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Marietta Wealth Management sold 120,000 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $67.2K.
Marietta Wealth Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2022 and held it in 6 quarters.
Marietta Wealth Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $252K in Q3 2022.
32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on Marietta Wealth Management's 13F filing for Q3 2023, filed 30 Oct 2023.